News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
157,698 Results
Type
Article (7618)
Company Profile (26)
Press Release (150053)
Multimedia
Podcasts (6)
Webinars (4)
Section
Business (53644)
Career Advice (358)
Deals (9481)
Drug Delivery (11)
Drug Development (19949)
Employer Resources (18)
FDA (3739)
Job Trends (3919)
News (85151)
Policy (6569)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
Academia (501)
Accelerated approval (12)
Adcomms (6)
Allergies (46)
Alliances (7419)
ALS (50)
Alzheimer's disease (372)
Antibody-drug conjugate (ADC) (87)
Approvals (3966)
Artificial intelligence (85)
Autoimmune disease (40)
Automation (4)
Bankruptcy (55)
Best Places to Work (3331)
BIOSECURE Act (4)
Biosimilars (60)
Biotechnology (18)
Bladder cancer (59)
Brain cancer (19)
Breast cancer (211)
Cancer (1480)
Cardiovascular disease (136)
Career advice (334)
Career pathing (5)
CAR-T (48)
CDC (26)
Cell therapy (134)
Cervical cancer (14)
Clinical research (18291)
Collaboration (279)
Company closure (1)
Compensation (210)
Complete response letters (11)
COVID-19 (651)
CRISPR (16)
C-suite (117)
Cystic fibrosis (31)
Data (2233)
Depression (44)
Diabetes (170)
Diagnostics (1453)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (31)
Drug pricing (33)
Drug shortages (1)
Duchenne muscular dystrophy (79)
Earnings (40859)
Editorial (13)
Employer branding (2)
Employer resources (16)
Events (22251)
Executive appointments (107)
FDA (4808)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (11)
Funding (233)
Gene editing (35)
Generative AI (5)
Gene therapy (130)
GLP-1 (312)
Government (941)
Grass and pollen (3)
Guidances (323)
Healthcare (4298)
HIV (23)
Huntington's disease (6)
IgA nephropathy (30)
Immunology and inflammation (81)
Immuno-oncology (17)
Indications (61)
Infectious disease (737)
Inflammatory bowel disease (51)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (51)
Interviews (48)
IPO (5892)
IRA (4)
Job creations (755)
Job search strategy (318)
JPM (7)
Kidney cancer (6)
Labor market (27)
Layoffs (144)
Leadership (1)
Legal (1214)
Liver cancer (20)
Longevity (3)
Lung cancer (217)
Lymphoma (138)
Machine learning (5)
Management (7)
Manufacturing (126)
MASH (57)
Medical device (3228)
Medtech (3243)
Mergers & acquisitions (3883)
Metabolic disorders (394)
mRNA (26)
Multiple sclerosis (63)
NASH (5)
Neurodegenerative disease (70)
Neuropsychiatric disorders (27)
Neuroscience (682)
NextGen: Class of 2026 (1362)
Non-profit (920)
Now hiring (7)
Obesity (163)
Opinion (29)
Ovarian cancer (60)
Pain (46)
Pancreatic cancer (61)
Parkinson's disease (62)
Partnered (6)
Patents (96)
Patient recruitment (94)
Peanut (25)
People (7314)
Pharmaceutical (9)
Pharmacy benefit managers (5)
Phase 1 (4628)
Phase 2 (7728)
Phase 3 (7347)
Pipeline (2632)
Policy (46)
Postmarket research (787)
Preclinical (1636)
Press Release (9)
Prostate cancer (96)
Psychedelics (8)
Radiopharmaceuticals (116)
Rare diseases (204)
Real estate (977)
Recruiting (6)
Regulatory (5609)
Reports (19)
Research institute (460)
Resumes & cover letters (41)
Rett syndrome (10)
RNA editing (5)
RSV (40)
Schizophrenia (38)
Series A (32)
Series B (28)
Service/supplier (1)
Sickle cell disease (25)
Special edition (16)
Spinal muscular atrophy (46)
Sponsored (8)
Startups (497)
Stomach cancer (5)
Supply chain (13)
Tariffs (18)
The Weekly (6)
Vaccines (300)
Venture capital (16)
Weight loss (113)
Women's health (20)
Worklife (1)
Date
Today (48)
Last 7 days (319)
Last 30 days (871)
Last 365 days (8746)
2026 (1256)
2025 (8781)
2024 (9455)
2023 (10669)
2022 (12589)
2021 (13394)
2020 (12173)
2019 (10318)
2018 (7684)
2017 (10866)
2016 (5960)
2015 (7933)
2014 (5567)
2013 (3713)
2012 (4117)
2011 (4301)
2010 (4210)
Location
Africa (276)
Alabama (11)
Alaska (1)
Arizona (42)
Arkansas (2)
Asia (9560)
Australia (1428)
California (3005)
Canada (1012)
China (333)
Colorado (171)
Connecticut (152)
Delaware (124)
Europe (24623)
Florida (381)
Georgia (117)
Idaho (9)
Illinois (209)
India (20)
Indiana (177)
Iowa (6)
Japan (159)
Kansas (40)
Kentucky (7)
Louisiana (11)
Maine (34)
Maryland (314)
Massachusetts (2161)
Michigan (90)
Minnesota (168)
Mississippi (4)
Missouri (30)
Montana (6)
Nebraska (3)
Nevada (48)
New Hampshire (21)
New Jersey (1064)
New Mexico (1)
New York (910)
North Carolina (435)
North Dakota (1)
Northern California (1526)
Ohio (56)
Oklahoma (1)
Oregon (3)
Pennsylvania (654)
Puerto Rico (5)
Rhode Island (2)
South America (370)
South Carolina (8)
Southern California (1214)
Tennessee (34)
Texas (409)
United States (10955)
Utah (82)
Virginia (57)
Washington D.C. (12)
Washington State (249)
Wisconsin (29)
157,698 Results for "17".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Satellos to Participate in Upcoming Investor Conferences - February 17, 2026
February 17, 2026
·
2 min read
Press Releases
Kyntra Bio to Participate in Upcoming Investor Conferences - February 17, 2026
February 18, 2026
·
1 min read
Press Releases
Adagene to Participate in Two Upcoming Investor Conferences - February 17, 2026
February 17, 2026
·
3 min read
Press Releases
Change to the Roche Enlarged Corporate Executive Committee - February 17, 2026
February 17, 2026
·
3 min read
Press Releases
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
February 18, 2026
·
1 min read
Press Releases
West Announces Quarterly Dividend and Share Repurchase Program - February 17, 2026
February 18, 2026
·
2 min read
Collaboration
Novartis Bets Up to $1.7B in Cardio-Focused Peptide Partnership
Novartis and Unnatural Products did not specify which disease targets they’re going after, only noting that the latter’s macrocyclic platform can generate potentially next-generation therapies that could apply to cardiovascular conditions.
February 19, 2026
·
2 min read
·
Tristan Manalac
Collaboration
Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer
In a Phase 1 study, 82% of patients on VIR-5500 achieved at least a 50% reduction in PSA levels—a result analysts praised as competitive in the prostate cancer space.
February 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Genmab Files Annual Report with the U.S. Securities and Exchange Commission - February 17, 2026
February 17, 2026
·
3 min read
Deals
Roche Keeps the Deals Coming With up to $1.7B SangeneBio RNAi Pact
The alliance will add to Roche’s RNAi efforts, which include the hypertension candidate zilbesiran, partnered with Alnylam under a July 2023 agreement.
February 3, 2026
·
1 min read
·
Tristan Manalac
1 of 15,770
Next
